Wednesday 19 February 2020

Safwan named Kuwait distributor for Boehringer

KUWAIT, December 25, 2019

Safwan Trading & Contracting, a subsidiary of Ali Abdulwahab Al Mutawa Commercial Company, has been appointed by Boehringer Ingelheim (BI), a global pharmaceutical company, as its exclusive distributor in Kuwait.

The agreement was signed at AAW headquarters in a ceremony attended by Safwan and BI representatives.

AAW chairman and CEO Faisal Ali Al Mutawa said: “We are honoured to be partnering with an international and world-renowned company like Boehringer Ingelheim. This partnership enables us to further develop the pharmaceutical sector in Kuwait and continue to provide the market with new medical and pharmaceutical products.”

Mazen Bachir, general manager & head of Human Pharma of GulfIP said: “Through our partnership with Safwan Trading & Contracting we are strengthening BI’s position towards better serving our customers and all of Kuwait’s residents. This is also in line with the country’s national programme designed to ensure the continued provision of quality healthcare with the support of the private sector.

“We are very proud of our local teams who have worked relentlessly towards a smooth transition, laying the foundations for a bright future ahead of our organization. We are privileged to have the opportunity to support Kuwait towards delivering its social commitment to provide top-notch universal healthcare.”

Safwan Trading & Contracting Co. is one of the top leading companies in Kuwait in the health care business, representing a considerable number of well-known multinational principals. Safwan has been in business since 1967 and is recognized as a major supplier of pharmaceuticals, medical equipment and supplies, and laboratory products. – TradeArabia News Service


More Health & Environment Stories

calendarCalendar of Events